Premium
NeOne Technologies Holdings Inc (NTHI)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
NeOnc Technologies Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies. Its lead product candidates include NEO100, a purified form of preillyl acid that is in Phase IIa clinical trial; and NEO212, a covalently conjugated molecul... NeOnc Technologies Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies. Its lead product candidates include NEO100, a purified form of preillyl acid that is in Phase IIa clinical trial; and NEO212, a covalently conjugated molecule combining chemotherapeutic drug temozolomide with perillyl alcohol that is in Phase I/II clinical trials for its oral administration for the treatment of primary brain cancers, such as meningioma, high grade gliomas, glioblastoma, and secondary brain cancers. The company was formerly known as NAS-ONC, Inc. and changed its name to NeOnc Technologies Holdings, Inc. in 2009. The company was incorporated in 2005 and is headquartered in Calabasas, California. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.1295 | 2.79094827586 | 4.64 | 4.94 | 4.24 | 42829 | 4.47691529 | CS |
| 4 | -0.8505 | -15.1334519573 | 5.62 | 5.9 | 4.16 | 46158 | 4.88160786 | CS |
| 12 | -3.1105 | -39.4733502538 | 7.88 | 8.15 | 3.87 | 68704 | 5.23698744 | CS |
| 26 | -4.6505 | -49.3683651805 | 9.42 | 11.3765 | 3.87 | 61897 | 7.11339615 | CS |
| 52 | -1.8305 | -27.7348484848 | 6.6 | 12.99 | 3.2 | 103778 | 6.73247059 | CS |
| 156 | -7.2805 | -60.4190871369 | 12.05 | 21 | 3.2 | 99208 | 6.82804308 | CS |
| 260 | -7.2805 | -60.4190871369 | 12.05 | 21 | 3.2 | 99208 | 6.82804308 | CS |
Transactions différées
Pour obtenir des transactions en temps réel, améliorez votre compte
Passer à la version en temps réel| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
